These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11409910)

  • 1. Extracorporeal photopheresis: a review.
    Oliven A; Shechter Y
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Photopheresis: new immunomodulatory therapy for T-lymphocite mediated diseases].
    Vagace Valero JM; Alonso Escobar N; De Argila Fernández-Durán D; Vargas Pérez L; Melero Ruiz J; Morán Penco JM; Bajo Gómez R; Pérez Miranda M
    An Med Interna; 2003 Aug; 20(8):421-6. PubMed ID: 14516265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photochemotherapy--present and future.
    Knobler R
    Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photopheresis: clinical applications and mechanism of action.
    Rook AH; Suchin KR; Kao DM; Yoo EK; Macey WH; DeNardo BJ; Bromely PG; Geng Y; Junkins-Hopkins JM; Lessin SR
    J Investig Dermatol Symp Proc; 1999 Sep; 4(1):85-90. PubMed ID: 10537015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance?
    Aubin F; Mousson C
    Transplantation; 2004 Jan; 77(1 Suppl):S29-31. PubMed ID: 14726767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracorporeal photochemotherapy for treatment of clonal T cell proliferations].
    Plumas J; Drillat P; Jacob MC; Richard MJ; Favrot MC
    Bull Cancer; 2003; 90(8-9):763-70. PubMed ID: 14609767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extracorporeal photochemotherapy].
    Viguier M; Pouthier F; Tiberghien P; Aubin F
    Transfus Clin Biol; 2010 Feb; 17(1):28-33. PubMed ID: 20042357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.
    Wolfe JT; Lessin SR; Singh AH; Rook AH
    Artif Organs; 1994 Dec; 18(12):888-97. PubMed ID: 7887825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
    Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
    Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications.
    Chiesa-Fuxench ZC; González-Chávez J
    P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis: technique, established and novel indications.
    Marques MB; Adamski J
    J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.